Eunhye Jeon - Search Results

Year	Number of Results
2021	3
2022	3
2023	2
2024	1

1

Targeted kinase degradation via the KLHDC2 ubiquitin E3 ligase.

Kim Y, Seo P, Jeon E, You I, Hwang K, Kim N, Tse J, Bae J, Choi HS, Hinshaw SM, Gray NS, Sim T. Kim Y, et al. Among authors: jeon e. Cell Chem Biol. 2023 Nov 16;30(11):1414-1420.e5. doi: 10.1016/j.chembiol.2023.07.008. Epub 2023 Aug 10. Cell Chem Biol. 2023. PMID: 37567174

2

RPL27 contributes to colorectal cancer proliferation and stemness via PLK1 signaling.

Park SY, Seo D, Jeon EH, Park JY, Jang BC, Kim JI, Im SS, Lee JH, Kim S, Cho CH, Lee YH. Park SY, et al. Int J Oncol. 2023 Aug;63(2):93. doi: 10.3892/ijo.2023.5541. Epub 2023 Jun 30. Int J Oncol. 2023. PMID: 37387446 Free PMC article.

3

Complete Genome Sequence of Stenotrophomonas maltophilia Podophage Paxi.

Jeon E, Hudson A, Talcott A, Clark J, Le T, Burrowes B, Liu M. Jeon E, et al. Microbiol Resour Announc. 2022 Apr 21;11(4):e0017922. doi: 10.1128/mra.00179-22. Epub 2022 Apr 4. Microbiol Resour Announc. 2022. PMID: 35377170 Free PMC article.

4

Novel Small Molecules Capable of Blocking mtRAS-Signaling Pathway.

Kim N, Shin I, Kim Y, Jeon E, Lee J, Lee C, Nam Y, Lee S, Ju E, Kim C, Son W, Ryu S, Ko M, Sim T. Kim N, et al. Among authors: jeon e. Front Oncol. 2021 Dec 9;11:768022. doi: 10.3389/fonc.2021.768022. eCollection 2021. Front Oncol. 2021. PMID: 34956887 Free PMC article.

5

Identification of Pyridinyltriazine Derivatives as Potent panFGFR Inhibitors against Gatekeeper Mutants for Overcoming Drug Resistance.

Ryu S, Nam Y, Kim N, Shin I, Jeon E, Kim Y, Kim ND, Sim T. Ryu S, et al. Among authors: jeon e. J Med Chem. 2022 Apr 28;65(8):6017-6038. doi: 10.1021/acs.jmedchem.1c01776. Epub 2022 Apr 18. J Med Chem. 2022. PMID: 35436119

6

RPL17 Promotes Colorectal Cancer Proliferation and Stemness through ERK and NEK2/β-catenin Signaling Pathways.

Ko MJ, Seo YR, Seo D, Park SY, Seo JH, Jeon EH, Kim SW, Park KU, Koo DB, Kim S, Bae JH, Song DK, Cho CH, Kim KS, Lee YH. Ko MJ, et al. J Cancer. 2022 May 13;13(8):2570-2583. doi: 10.7150/jca.69428. eCollection 2022. J Cancer. 2022. PMID: 35711835 Free PMC article.

7

Identification of Thieno[3,2-d]pyrimidine Derivatives as Dual Inhibitors of Focal Adhesion Kinase and FMS-like Tyrosine Kinase 3.

Cho H, Shin I, Yoon H, Jeon E, Lee J, Kim Y, Ryu S, Song C, Kwon NH, Moon Y, Kim S, Kim ND, Choi HG, Sim T. Cho H, et al. Among authors: jeon e. J Med Chem. 2021 Aug 26;64(16):11934-11957. doi: 10.1021/acs.jmedchem.1c00459. Epub 2021 Jul 29. J Med Chem. 2021. PMID: 34324343

8

Novel and Potent Small Molecules against Melanoma Harboring BRAF Class I/II/III Mutants for Overcoming Drug Resistance.

Kim N, Shin I, Lee J, Jeon E, Kim Y, Ryu S, Ju E, Cho W, Sim T. Kim N, et al. Among authors: jeon e. Int J Mol Sci. 2021 Apr 6;22(7):3783. doi: 10.3390/ijms22073783. Int J Mol Sci. 2021. PMID: 33917428 Free PMC article.

9

Site-specific mutagenesis screening in KRAS^G12D mutant library to uncover resistance mechanisms to KRAS^G12D inhibitors.

Choi J, Shin JY, Kim TK, Kim K, Kim J, Jeon E, Park J, Han YD, Kim KA, Sim T, Kim HK, Kim HS. Choi J, et al. Among authors: jeon e. Cancer Lett. 2024 Apr 18;591:216904. doi: 10.1016/j.canlet.2024.216904. Online ahead of print. Cancer Lett. 2024. PMID: 38642608

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year